TOMÍŠKOVÁ, Marcela, Jana KAPLANOVÁ and Jana SKŘIČKOVÁ. Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer. Journal of Thoracic Oncology. Geneva, 2008, vol. 3, No 4, p. 80-83. ISSN 1556-0864.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer
Name in Czech Analýza klinických faktorů ve vztahu k léčbě účinků erlotinibu u nemaluněčného karcinomu
Authors TOMÍŠKOVÁ, Marcela (203 Czech Republic), Jana KAPLANOVÁ (203 Czech Republic) and Jana SKŘIČKOVÁ (203 Czech Republic, guarantor).
Edition Journal of Thoracic Oncology, Geneva, 2008, 1556-0864.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.508
RIV identification code RIV/00216224:14110/08:00033464
Organization unit Faculty of Medicine
Keywords (in Czech) nemalobunčný karcinom; léčba erlotinibem
Keywords in English non small cell lung cancer; erlotinib; treatment
Tags erlotinib, treatment
Changed by Changed by: prof. MUDr. Jana Skřičková, CSc., učo 1808. Changed: 31/3/2010 14:03.
Abstract
Different clinical factors were evaluated in relationship to the treatment of non-small cell lung cancer with erlotinib.
Abstract (in Czech)
Byla provedena analýza klinických faktorů ve vztahu k léčbě účinků erlotinibu u nemaluněčného karcinomu.
Links
MSM 141100003, plan (intention)Name: Zevní prostředí - karcinogeneze - onkologie
Investor: Ministry of Education, Youth and Sports of the CR, Environment - carcinogenesis - oncology
PrintDisplayed: 1/7/2024 06:47